Biologics Legislation

RA Guy Community News

Eshoo bill huge boon for Silicon Valley biotech

Buried in the giant health care bills in Congress is a multibillion-dollar bonanza for Silicon Valley’s biotechnology and venture capital industries, sponsored by Rep. Anna Eshoo, a Palo Alto Democrat.

The provision would grant “biologic” drugs, a new class of drugs based on gene splicing and grown in living cells, 12 years of protection from competition by the generic drug industry, in addition to their patents.

A scathing report by the Federal Trade Commission in June said no added protection, much less 12 years, was warranted, and warned that the Eshoo legislation would ensure sky-high drug prices and stifle innovation on the most promising frontier of medical research.

Read More: http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2009/12/06/MNFQ1AV2C3.DTL